Canadian Community Utilization of Stroke Prevention Study - Emergency Department "C-CUSP ED"

Active, not recruiting

Phase N/A Results N/A

Update History

22 Sep '17
The Summary of Purpose was updated.
New
Atrial fibrillation (AF) is a common heart condition, and increases the risk of stroke by six times. There are several medications (blood thinners) that can prevent strokes in AF patients. Many AF patients present to the emergency department, but about half of AF patients leave without prescription of a blood thinner. The study aims to evaluate if adding options like giving a patient education kit, encouraging emergency room physicians to prescribe a blood thinner and providing a specialized AF clinic to patients will increase the number patients receiving blood thinners to prevent strokes.
Old
Atrial fibrillation (AF) is a common heart condition, and increases the risk of stroke by six times. There are several medications (blood thinners) that can prevent strokes in AF patients. Many AF patients present to the emergency department, but about half of AF patients leave without prescription of a blood thinner. The study aims to evaluate if adding options like giving a patient education kit, encouraging emergency room physicians to prescribe a blood thinner and providing a specialized AF clinic to patients will increase the number patients receiving blood thinners to prevent strokes.
The description was updated.
New
This is a knowledge translation study will occur in three consecutive phases: Phase 1 is a retrospective chart review of all patients who presented to the emergency department (ED) with ECG documented AF during 1 year prior to study commencement. The main purpose of Phase 1 is to determine if oral anticoagulants (OACs) were prescribed for eligible AF patients at ED discharge. In Phase 2 a low-intensity intervention will be applied in the ED during 6 months, involving physician education, distribution of an AF patient education package, short-term OAC prescription, and a follow-up letter to the patient's family physician. After a one month transition phase, a high intensity intervention will be applied during 6 months in Phase 3. Phase 3 incorporates the Phase 2 intervention, and adds immediate follow-up (within 48-72 hours) in a community AF clinic run by a nurse/pharmacist who is supervised by a specialist in AF.
Old
This is a knowledge translation study will occur in three consecutive phases: Phase 1 is a retrospective chart review of all patients who presented to the emergency department (ED) with ECG documented AF during 1 year prior to study commencement. The main purpose of Phase 1 is to determine if oral anticoagulants (OACs) were prescribed for eligible AF patients at ED discharge. In Phase 2 a low-intensity intervention will be applied in the ED during 6 months, involving physician education, distribution of an AF patient education package, short-term OAC prescription, and a follow-up letter to the patient's family physician. After a one month transition phase, a high intensity intervention will be applied during 6 months in Phase 3. Phase 3 incorporates the Phase 2 intervention, and adds immediate follow-up (within 48-72 hours) in a community AF clinic run by a nurse/pharmacist who is supervised by a specialist in AF.
The gender criteria for eligibility was updated to "All."
A location was updated in North Vancouver.
New
The overall status was removed for Lions Gate Hospital.
A location was updated in Moncton.
New
The overall status was removed for Dr. Georges-L.-Dumont University Hospital Centre.
A location was updated in Dartmouth.
New
The overall status was removed for Dartmouth General Hospital.
A location was updated in Halifax.
New
The overall status was removed for Halifax Infirmary.
15 Dec '15
The description was updated.
New
This is a knowledge translation study will occur in three consecutive phases: Phase 1 is a retrospective chart review of all patients who presented to the emergency department (ED) with ECG documented AF during 1 year prior to study commencement. The main purpose of Phase 1 is to determine if oral anticoagulants (OACs) were prescribed for eligible AF patients at ED discharge. In Phase 2 a low-intensity intervention will be applied in the ED during 6 months, involving physician education, distribution of an AF patient education package, short-term OAC prescription, and a follow-up letter to the patient's family physician. After a one month transition phase, a high intensity intervention will be applied during 6 months in Phase 3. Phase 3 incorporates the Phase 2 intervention, and adds immediate follow-up (within 48-72 hours) in a community AF clinic run by a nurse/pharmacist who is supervised by a specialist in AF.
Old
This is a knowledge translation study will occur in three consecutive phases: Phase 1 is a retrospective chart review of all patients who presented to the emergency department (ED) with ECG documented AF during 1 year prior to study commencement. The main purpose of Phase 1 is to determine if oral anticoagulants (OACs) were prescribed for eligible AF patients at ED discharge. In Phase 2 a low-intensity intervention will be applied in the ED during 6 months, involving physician education, distribution of an AF patient education package, short-term OAC prescription, and a follow-up letter to the patient's family physician. After a one month transition phase, a high intensity intervention will be applied during 6 months in Phase 3. Phase 3 incorporates the Phase 2 intervention, and adds immediate follow-up (within 48-72 hours) in a community AF clinic run by a nurse/pharmacist who is supervised by a specialist in AF.
A location was updated in North Vancouver.
New
The overall status was removed for Lions Gate Hospital.
18 Jul '15
A location was updated in Halifax.
New
The overall status was removed for Halifax Infirmary.
25 Jun '15
The eligibility criteria were updated.
New
Inclusion Criteria: - Patients who present to the emergency department with electrocardiographically documented atrial fibrillation on a 12 lead ECG Exclusion Criteria: - Prosthetic or mechanical mitral or aortic valve - Known rheumatic heart disease - Unable to provide informed consent - Will be admitted to hospital - Life expectancy of < 6 months - Metastatic malignancy
Old
Inclusion Criteria: - Patients who present to the emergency department with electrocardiographically documented atrial fibrillation on a 12 lead ECG Exclusion Criteria: - Prosthetic or mechanical mitral or aortic valve - Known rheumatic disease - Unable to provide informed consent - Will be admitted to hospital - Life expectancy of < 6 months - Metastatic malignancy
A location was updated in Moncton.
New
The overall status was removed for Dr. Georges-L.-Dumont University Hospital Centre.